ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice

Wyss-Coray, T*; Lin, C; Yan, FR; Yu, GQ; Rohde, M; McConlogue, L; Masliah, E; Mucke, L
Nature Medicine2001-5DOI: 10.1038/87945
511被引2阅读
引用收藏
分享

摘要

Abnormal accumulation of the amyloid-beta peptide (A beta) in the brain appears crucial to pathogenesis in all forms of Alzheimer disease (AD), but the underlying mechanisms in the sporadic forms of AD remain unknown. Transforming growth factor beta1 (TGF-beta1), a key regulator of the brain's responses to injury and inflammation, has been implicated in A beta Delta deposition in vivo. Here we demonstrate that a modest increase in astroglial TGF-beta1 production in aged transgenic mice expressing the human beta -amyloid precursor protein (hAPP) results in a three-fold reduction in the number of parenchymal amyloid plaques, a 50% reduction in the overall A beta load in the hippocampus and neocortex, and a decrease in the number of dystrophic neurites. In mice expressing hAPP and TGF-beta1, A beta accumulated substantially in cerebral blood vessels, but not in parenchymal plaques. In human cases of AD, A beta immunoreactivity associated with parenchymal plaques was inversely correlated with A beta in blood vessels and cortical TGF-beta1 mRNA levels. The reduction of parenchymal plaques in hAPP/TGF-beta1 mice was associated with a strong activation of microglia and an increase in inflammatory mediators. Recombinant TGF-beta1 stimulated A beta clearance in microglial cell cultures. These results demonstrate that TGF-beta1 is an important modifier of amyloid deposition in vivo and indicate that TGF-beta1 might promote microglial processes that inhibit the accumulation of A beta in the brain parenchyma.

学科与关键词

关键词
CENTRAL-NERVOUS-SYSTEMDISEASE-LIKE PATHOLOGYE EPSILON-4 ALLELEALZHEIMERS-DISEASEPRECURSOR PROTEINAPOLIPOPROTEIN-EMOUSE MODELTRANSFORMING GROWTH-FACTOR-BETA-1CELL BIOLOGYHEAD-INJURY
相关
加载中…
  • Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease
    Xu, Yi-Jun; Au, Ngan Pan Bennett; Ma, Chi Him Eddie*Frontiers in Aging Neuroscience, 2022, 14: 896852.被引 16
  • Brain plasmin enhances APP α-cleavage and Aβ degradation and is reduced in Alzheimer's disease brains
    Ledesma, MD; Da Silva, JS; Crassaerts, K; Delacourte, A; De Strooper, B; Dotti, CG*EMBO Reports, 2000, 1(6): 530-535.被引 185
  • Treadmill Exercise Promotes Microglial β-Amyloid Clearance and Prevents Cognitive Decline in APP/PS1 Mice
    Liang, Fei*; Sun, Feng; He, Biao; Wang, JingNeuroscience, 2022, 491: 122-133.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Nature Medicine
发表日期
2001-05
卷期
第 7 卷, 第 5 期
页码
612-618
DOI
10.1038/87945
语言
ENGLISH
成果收录
SCIE
资助标注
NIA NIH HHS [AG-15871, AG-51131, AG-10689, AG-11385] Funding Source: Medline

作者

  • W

    Wyss-Coray, T (通讯) (第一作者)

  • L

    Lin, C

查看全部 8 位作者收起作者
  • Y

    Yan, FR

  • Y

    Yu, GQ

  • R

    Rohde, M

  • M

    McConlogue, L

  • M

    Masliah, E

  • M

    Mucke, L

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417